We therefore analyzed the hepatocellular carcinoma tumor xenografts for the potential anti-proliferative effects of DE605 plus sorafenib using immunohistochemical detection of Ki-67-positive cells. This evidence concerns the gene MKI67 and hepatocellular carcinoma.